Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

NZ Team In Stroke Breakthrough

$30m clinical trial succeeds in reducing stroke and heart attack

Auckland, 11 July 2001: An Auckland University team of scientists has won international recognition for a new treatment that dramatically improves outcomes for people at risk of stroke or heart attack.

Worldwide, more than 40 million people are now living with the effects of a stroke and many millions more have had a “mini-stroke” transient ischaemic attack (TIA). Victims of a first attack remain at high risk, with one in five suffering another stroke or a heart attack within five years.

The study found patients taking an ACE inhibitor drug, perindopril, together with a diuretic indapamide reduced their risk of a second stroke or related heart attack by 25–50 percent.

The $30m trial was initiated at the Clinical Trials Research Unit (CTRU) at the University of Auckland, with a contract managed by Auckland UniServices Limited.

“Many stroke victims can now be spared unnecessary suffering,“ said Dr Anthony Rodgers, Co-Director of the CTRU, confirming the results of PROGRESS, or the Perindopril Protection Against Recurrent Stroke Study. “This is the first treatment that is both highly effective and applicable to the vast majority of patients”

“Involving over 6000 patients in Europe, Asia and Australasia at 172 hospitals for six years was a major undertaking,” said Rochelle Currie, the Project Manager. The trial was New Zealand’s biggest health research contract, and the first anywhere in the world to include both large European and Asian populations in a study of a cerebrovascular disease.

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

Announced in Milan to the European Society of Hypertension, the Auckland team’s findings have been hailed as a breakthrough by medical researchers and were reported by CNN, The New York Times, and leading European and Asian news organisations.

The research was supported by grants from France’s Institut de Recherches Internationales Servier, the Health Research Council of New Zealand and the National Health & Medical Research Council of Australia.

About 18,000 New Zealanders are now living with the effects of a stroke, a number expected to double over the next two decades.

Ends

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
GenPro: General Practices Begin Issuing Clause 14 Notices

GenPro has been copied into a rising number of Clause 14 notices issued since the NZNO lodged its Primary Practice Pay Equity Claim against General Practice employers in December 2023.More

SPADA: Screen Industry Unites For Streaming Platform Regulation & Intellectual Property Protections

In an unprecedented international collaboration, representatives of screen producing organisations from around the world have released a joint statement.More

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.